Burke Neurological Institute
Menu
Skip to main content
Our Team
Contact Us
Donate
Clinical Trials
Search form
Search
About Us
Conditions
Faculty / Research Labs & Core Facilities
News & Impact
Future Talent
Events
About Us
+
About the Institute
Our Mission & Vision
Our History
Our Leadership
Our Boards
Our Team
Affiliations & Partners
Funding Sources
Brand Toolkit
Research Compliance
Campus Guide
Contact Us
Conditions
+
Neurological Conditions
Stroke
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Neurodegenerative Diseases
Retinal Degenerative Diseases
Neurological Recovery
Motor Recovery
Pain & Sensory Recovery
Cognitive Recovery
Vision Recovery
Find a Clinical Trial
Inquire About Trials
Research Registry
Center for Pain & Sensory
Center for Vision Repair
Resilience Program
Campus Guide
Faculty / Research Labs & Core Facilities
+
Research Labs & Cores
Cho Lab
Friel Lab
Gibson Lab
Hussaini Lab
Hollis Lab
Marshel Lab
Prusky Lab
Ratan Lab
Sahni Lab
Travis Lab
Willis Lab
Yoshida Lab
Imaging Core
SCI Core
Research Methods
News & Impact
+
Recent News & Impact
News
Publications
Grants
Presentations
Future Talent
+
Programs & Opportunities
Open Job Positions
Summer Science
Intro to Neuroscience
NeuroAcademy
Postdoctoral Fellow
Graduate Medical Fellow
Undergraduate
High School
Events
+
Upcoming Events
Archived Events
Webinar Series
You are here
Home
>
Drug Discovery
Drug Discovery
Impact
Gibson Lab
PUBLICATION:
Journal Article
Freeman GB, Gibson GE.
Effect of decreased oxygen on in vitro release of endogenous 3,4-dihydroxyphenylethylamine from mouse striatum.
J Neurochem. 1986 Dec;47(6):1924-31.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Freeman GB, Nielsen P, Gibson GE.
Behavioral and neurochemical correlates of morphine and hypoxia interactions.
Pharmacol Biochem Behav. 1986 Jun;24(6):1687-93.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Nicholls DG, Gibson GE.
Subsynaptosomal calcium distribution during hypoxia and 3,4-diaminopyridine treatment.
J Neurochem. 1985 Dec;45(6):1779-90.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Nicholls DG, Gibson GE.
Subsynaptosomal distribution of calcium during aging and 3,4-diaminopyridine treatment.
Neurobiol Aging. 1985 Winter;6(4):297-304.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Hirsch JA, Gibson GE.
Thiamin antagonists and the release of acetylcholine and norepinephrine from brain slices.
Biochem Pharmacol. 1984 Jul 15;33(14):2325-7. No abstract available.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Gibson GE.
Synaptosomal calcium metabolism during hypoxia and 3,4-diaminopyridine treatment.
J Neurochem. 1984 Jan;42(1):248-53.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Gibson GE.
Aging and 3,4-diaminopyridine alter synaptosomal calcium uptake.
J Biol Chem. 1983 Oct 10;258(19):11482-6.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Gibson GE, Pelmas CJ, Peterson C.
Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits.
Pharmacol Biochem Behav. 1983 Jun;18(6):909-16.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Gibson GE.
Amelioration of age-related neurochemical and behavioral deficits by 3,4-diaminopyridine.
Neurobiol Aging. 1983 Spring;4(1):25-30.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Davis HP, Idowu A, Gibson GE.
Improvement of 8-arm maze performance in aged Fischer 344 rats with 3,4-diaminopyridine.
Exp Aging Res. 1983 Fall;9(3):211-4.
Abstract on PubMed
« first
‹ previous
…
7
8
9
10
11
12
13
14
(current)
15
next ›
last »
Causes
Neurodegenerative Diseases
,
Stroke
,
Spinal Cord Injury
,
Retinal Degenerative Diseases
,
Cognitive Recovery
,
Vision Recovery